Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Sodium Bicarbonate Solution	NCIT_C88262	[An aqueous oral mouthwash solution containing the monosodium salt of carbonic acid with alkalinizing and antimucositis activities. Upon introduction into the mouth, the sodium bicarbonate dissociates, forming sodium and bicarbonate ions, which buffer excess hydrogen ion and elevates the oral pH. An alkaline oral environment is less prone to colonization with yeast and aciduric bacteria. In addition, this solution may help relieve mucositis and mucositis-induced pain by diluting human saliva, and cleansing and lubricating mucosal tissues of the mouth, tongue and oropharynx.]
Fluorine F 18 Fluoro Furanyl Norprogesterone	NCIT_C88263	[The progesterone derivative fluoro furanyl norprogesterone (FFNP), radiolabeled with fluorine F 18, with positron-emitting radioligand activity. Upon injection, fluorine F 18 fluoro furanyl norprogesterone (F18-FFNP) binds to progesterone receptors (PgR) in progesterone-responsive tissues. In PgR-positive breast cancer, positron emission tomography (PET) may then be used to quantitate hormone receptor status.]
Mycosis Fungoides and Sezary Syndrome Distant Metastasis-Visceral TNM Finding v7	NCIT_C88246	[A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases (visceral). (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome TNM Finding v7	NCIT_C88229	[A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v7 classification system.]
Mycosis Fungoides and Sezary Syndrome M0 TNM Finding v7	NCIT_C88247	[No visceral organ involvement. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome M1 TNM Finding v7	NCIT_C88248	[Visceral involvement (must have pathology confirmation and organ involved should be specified). Note: for viscera, spleen and liver may be diagnosed by imaging criteria. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome Peripheral Blood Involvement TNM Finding v7	NCIT_C88249	[A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v7 classification system as they pertain to peripheral blood involvement. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome B1 TNM Finding v7	NCIT_C88253	[Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary) cells but does not meet the criteria of B2. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome B1a TNM Finding v7	NCIT_C88254	[Clone negative. Note: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome B1b TNM Finding v7	NCIT_C88255	[Clone positive. Note: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome B2 TNM Finding v7	NCIT_C88256	[High blood tumor burden: 1000/microL Sezary cells or more with positive clone. Note 1: for blood, Sezary cells are defined as lymphocytes with hyperconvoluted cerebriform nuclei. If Sezary cells are not able to be used to determine tumor burden for B2, then one of the following modified ISCL criteria along with a positive clonal rearrangement of the TCR may be used instead: (1) expanded CD4+ or CD3+ cells with CD4/CD8 ratio of 10 or more, (2) expanded CD4+ cells with abnormal immunophenotype including loss of CD7 or CD26. Note 2: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome B0 TNM Finding v7	NCIT_C88250	[Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). Note: for blood, Sezary cells are defined as lymphocytes with hyperconvoluted cerebriform nuclei. If Sezary cells are not able to be used to determine tumor burden for B2, then one of the following modified ISCL criteria along with a positive clonal rearrangement of the TCR may be used instead: (1) expanded CD4+ or CD3+ cells with CD4/CD8 ratio of 10 or more, (2) expanded CD4+ cells with abnormal immunophenotype including loss of CD7 or CD26. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome B0a TNM Finding v7	NCIT_C88251	[Clone negative. Note: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome B0b TNM Finding v7	NCIT_C88252	[Clone positive. Note: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome N1a TNM Finding v7	NCIT_C88239	[Clone negative. Note: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome N1 TNM Finding v7	NCIT_C88238	[Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. Note: Dutch grade 1: dermatopathic lymphadenopathy. NCI LN0: no atypical lymphocytes. NCI LN1: occasional and isolated atypical lymphocytes (not arranged in clusters). NCI LN2: many atypical lymphocytes or in 3-6 cell clusters. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome T4 TNM Finding v7	NCIT_C88235	[Confluence of erythema covering 80% or more of body surface area. (from AJCC 7th Ed.)]
Mycosis Fungoides and Sezary Syndrome Primary Tumor-Skin TNM Finding v7	NCIT_C88230	[A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor (skin).]
Mycosis Fungoides and Sezary Syndrome Lymph Nodes TNM Finding v7	NCIT_C88236	[A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v7 classification system as they pertain to staging of peripheral lymph nodes.]
Mycosis Fungoides and Sezary Syndrome N0 TNM Finding v7	NCIT_C88237	[No clinically abnormal peripheral lymph nodes; biopsy not required. Note: for node, abnormal peripheral lymph node(s) indicates any palpable peripheral node that on physical examination is firm, irregular, clustered, fixed or 1.5 cm or larger in diameter. Node groups examined on physical examination include cervical, supraclavicular, epitrochlear, axillary, and inguinal. Central nodes, which are not generally amenable to pathologic assessment, are not currently considered in the nodal classification unless used to establish N3 histopathology. (from AJCC 7th Ed.)]